跳至主要内容
临床试验/EUCTR2005-000461-18-GB
EUCTR2005-000461-18-GB进行中(未招募)1 期

Study to Determine if The Cardiovascular risk indices in Type 2 diabetes are similar for Polycystic Ovarian Syndrome, and whether they may be modified by Therapy - Cardiovascular risk in PCOS as compared to type 2 Diabetes

niversity of Hull0 个研究点目标入组 48 人开始时间: 2005年2月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Inclusion criteria for polycystic ovarian syndrome: Age 40-50.
  • Polycystic ovarian syndrome (Rotterdam consensus criteria): irregular menses since menarche, oligomenorrhoea, clinical or biochemical hyperandrogenism, polycystic ovaries on ultrasound scanning.
  • Inclusion criteria for diabetes:Age 40-50
  • diabetes (diagnosed by WHO criteria)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria for polycystic ovarian syndrome:
  • Peri-menopausal symptoms,
  • Patient should not be on any medication, Unwilling for GP to be informed, Impaired glucose tolerance/ diabetes on GTT
  • Exclusion criteria for impaired glucose tolerance:
  • Peri-menopausal symptoms, Patient should not be on any medication, Unwilling for GP to be informed, Polycystic ovarian syndrome (patients must have regular periods, no clinical or biochemical evidence of hyperandrogenism, normal ovaries on ultrasound scanning

研究者

发起方
niversity of Hull

相似试验